⌘K
t
Funding Circle Holdings plc announced on 20 December 2022 that Geeta Gopalan, a Non-Executive Director of Funding Circle, will be appointed as a Non-Executive Director to the Board of Dechra Pharmaceuticals PLC. This appointment takes effect from 1 January 2023 and was made in accordance with Listing Rule LR 9.6.14(2).
| Date | 20 Dec 2022 |
| Time | 10:00:01 |
| Category | Miscellaneous |
| ID | 3124K |
20 December 2022
LEI: 2138003EK6UAINBBUS19
Funding Circle Holdings plc (the "Company")
Director Declaration
In accordance with Listing Rule LR 9.6.14(2), the Company announces that Geeta Gopalan, a Non-Executive Director of the Company, will be appointed as a Non-Executive Director to the Board of Dechra Pharmaceuticals PLC with effect from 1 January 2023.
END
Enquiries:
Funding Circle Investor Relations
Morten Singleton (+44 7736 297 929)
ir@fundingcircle.com
Funding Circle Media Relations
Abigail Whittaker (+44 7989 876136)
press@fundingcircle.com
Headland Consultancy
Mike Smith / Stephen Malthouse (+44 20 3805 4822)
About Funding Circle:
Funding Circle (LSE: FCH) is a lending platform for small business borrowers. Established in the UK in 2010, and now the leading lending platform to SMEs, the Group also has a material and growing presence in the US. Globally, Funding Circle has provided £14.5bn in loans to c.130,000 businesses. For small business borrowers, Funding Circle provides a leading-edge customer experience, delivered through its technology, machine learning, and data science, coupled with a human touch. Its solutions continue to help customers access the funding they need to succeed. For lending investors, Funding Circle provides access to an alternative asset class in an underserved market, and delivers robust and attractive returns.